Cypherpunk warned on Nasdaq $1 bid-price rule
Cypherpunk Technologies Inc. received a notice from Nasdaq that its common stock has closed below the required $1.00 per share minimum bid price for 30 consecutive business days, putting it out of compliance with Nasdaq Listing Rule 5550(a)(2).
Rhea-AI Filing Summary
Cypherpunk Technologies Inc. received a notice from Nasdaq that its common stock has closed below the required $1.00 per share minimum bid price for 30 consecutive business days, putting it out of compliance with Nasdaq Listing Rule 5550(a)(2).
The notice is a deficiency warning, not an immediate delisting, and the stock continues to trade on the Nasdaq Capital Market. The company has 180 days, until August 31, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for 10 straight business days, and may qualify for an additional 180-day period if other listing standards are met.
Cypherpunk plans to monitor its share price and may pursue options such as a reverse stock split to restore compliance, but there is no assurance it will succeed within the initial or any additional compliance period.
Positive
- None.
Negative
- Nasdaq minimum bid-price noncompliance and delisting risk: Cypherpunk’s stock has stayed below the $1.00 minimum bid for 30 consecutive business days, starting a 180-day cure period with only conditional prospects for an extension and no assurance of regaining compliance.
Insights
Nasdaq bid-price noncompliance introduces real delisting risk for Cypherpunk.
Cypherpunk Technologies Inc. has fallen below Nasdaq’s $1.00 minimum bid requirement for 30 consecutive business days. This triggers a formal deficiency period but not an immediate delisting, so the shares continue to trade on the Nasdaq Capital Market for now.
The company has until August 31, 2026 to achieve at least $1.00 closing bid for 10 consecutive business days. Nasdaq may grant an extra 180 days if other initial listing criteria, like market value of publicly held shares, are satisfied and Cypherpunk commits in writing to cure the deficiency.
Management notes it may consider actions including a reverse stock split, which can mechanically lift the share price but does not change underlying value. Actual outcomes will depend on share price performance and any corporate actions disclosed in future periodic or current reports.
8-K Event Classification
AI-generated analysis. How Rhea-AI works. Not financial advice.